Transcatheter arterial embolization for unruptured renal angiomyolipoma using a 1.8-Fr tip microballoon catheter with a mixture of ethanol and Lipiodol.
Embolization
Interventional radiology
Microballoon catheter
Renal angiomyolipoma
Journal
CVIR endovascular
ISSN: 2520-8934
Titre abrégé: CVIR Endovasc
Pays: Switzerland
ID NLM: 101738484
Informations de publication
Date de publication:
08 Jan 2020
08 Jan 2020
Historique:
received:
07
11
2019
accepted:
30
12
2019
entrez:
7
2
2020
pubmed:
7
2
2020
medline:
7
2
2020
Statut:
epublish
Résumé
To evaluate the efficacy and safety of transcatheter arterial embolization for renal angiomyolipoma using a 1.8-French tip microballoon catheter and a mixture of ethanol and Lipiodol. Seven consecutive patients with total of eight angiomyolipomas underwent this procedure between June 2014 and June 2017. A 1.8-French tip microballoon catheter was advanced to the feeding artery of the angiomyolipoma, and transcatheter arterial embolization was performed with a mixture of ethanol and Lipiodol under microballoon inflation. We retrospectively evaluated the characteristics of angiomyolipomas, technical success rate, clinical success rate, renal function, and adverse events. Technical success and clinical success were defined as complete embolization of all feeding arteries and reduction of tumor size, respectively. The median size of the angiomyolipomas was 46 mm (range, 40-64 mm). Transcatheter arterial embolization was successful in all eight angiomyolipomas. The median volume of the mixture of ethanol and Lipiodol was 6.0 ml (range, 2.0-14 ml). The median ratio of ethanol to Lipiodol was 71% (range, 71-75%). All eight angiomyolipomas shrank with a median shrinkage rate of 34% in diameter (range, 9-63%) and 77% in volume (range, 48-94%). The median follow-up period was 13 months (range, 9-54 months). Clinical success was achieved in all cases. Serum creatinine concentrations and the pre- and post-procedural estimated glomerular filtration rates did not change notably, and there were no major complications. Transcatheter arterial embolization for renal angiomyolipoma using a 1.8-French tip microballoon catheter with a mixture of ethanol and Lipiodol is effective and safe.
Sections du résumé
BACKGROUND
BACKGROUND
To evaluate the efficacy and safety of transcatheter arterial embolization for renal angiomyolipoma using a 1.8-French tip microballoon catheter and a mixture of ethanol and Lipiodol.
METHODS
METHODS
Seven consecutive patients with total of eight angiomyolipomas underwent this procedure between June 2014 and June 2017. A 1.8-French tip microballoon catheter was advanced to the feeding artery of the angiomyolipoma, and transcatheter arterial embolization was performed with a mixture of ethanol and Lipiodol under microballoon inflation. We retrospectively evaluated the characteristics of angiomyolipomas, technical success rate, clinical success rate, renal function, and adverse events. Technical success and clinical success were defined as complete embolization of all feeding arteries and reduction of tumor size, respectively.
RESULTS
RESULTS
The median size of the angiomyolipomas was 46 mm (range, 40-64 mm). Transcatheter arterial embolization was successful in all eight angiomyolipomas. The median volume of the mixture of ethanol and Lipiodol was 6.0 ml (range, 2.0-14 ml). The median ratio of ethanol to Lipiodol was 71% (range, 71-75%). All eight angiomyolipomas shrank with a median shrinkage rate of 34% in diameter (range, 9-63%) and 77% in volume (range, 48-94%). The median follow-up period was 13 months (range, 9-54 months). Clinical success was achieved in all cases. Serum creatinine concentrations and the pre- and post-procedural estimated glomerular filtration rates did not change notably, and there were no major complications.
CONCLUSION
CONCLUSIONS
Transcatheter arterial embolization for renal angiomyolipoma using a 1.8-French tip microballoon catheter with a mixture of ethanol and Lipiodol is effective and safe.
Identifiants
pubmed: 32027014
doi: 10.1186/s42155-019-0095-8
pii: 10.1186/s42155-019-0095-8
pmc: PMC6966394
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3Références
Clin Radiol. 2006 Jun;61(6):520-6
pubmed: 16713423
Minim Invasive Ther Allied Technol. 2015 Apr;24(2):94-100
pubmed: 25263680
J Vasc Interv Radiol. 2015 Jul;26(7):1018-24
pubmed: 25680280
Curr Urol Rep. 2017 May;18(5):36
pubmed: 28299630
Minim Invasive Ther Allied Technol. 2017 Jun;26(3):177-181
pubmed: 27801607
Invest Radiol. 1986 Jul;21(7):577-80
pubmed: 3015829
Eur Radiol. 2014 Aug;24(8):1785-93
pubmed: 24889998
J Urol. 1986 Jun;135(6):1121-4
pubmed: 3520013
Radiology. 2002 Oct;225(1):78-82
pubmed: 12354988
Pediatr Neurol. 2013 Oct;49(4):243-54
pubmed: 24053982
Cardiovasc Intervent Radiol. 2017 Dec;40(12):1933-1939
pubmed: 28685379
J Urol. 1969 Oct;102(4):396-401
pubmed: 5343474
J Urol. 2016 Apr;195(4 Pt 1):834-46
pubmed: 26612197
J Vasc Interv Radiol. 2005 Jan;16(1):45-50
pubmed: 15640409
Anticancer Res. 2017 Jun;37(6):3183-3187
pubmed: 28551662
J Vasc Interv Radiol. 2009 Jun;20(6):819-23
pubmed: 19465308
J Urol. 2015 Sep;194(3):635-9
pubmed: 25916674
J Vasc Interv Radiol. 2006 Feb;17(2 Pt 1):253-62
pubmed: 16517770
Cardiovasc Intervent Radiol. 2018 Apr;41(4):525-536
pubmed: 29260305
J Vasc Interv Radiol. 2011 Oct;22(10):1388-95
pubmed: 21757371
Cardiovasc Intervent Radiol. 2019 Jun;42(6):853-862
pubmed: 30843093
J Vasc Interv Radiol. 2009 Jan;20(1):39-45; quiz 45
pubmed: 19028113
Minim Invasive Ther Allied Technol. 2016;25(1):22-8
pubmed: 26406612
Minim Invasive Ther Allied Technol. 2018 Feb;27(1):2-10
pubmed: 29113514
J Urol. 1993 Dec;150(6):1782-6
pubmed: 8230504
J Vasc Interv Radiol. 2001 May;12(5):595-600
pubmed: 11340138
Cardiovasc Intervent Radiol. 2014 Oct;37(5):1220-5
pubmed: 24232038